Exodus Point Capital Management, LP Arcutis Biotherapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 323,701 shares of ARQT stock, worth $3.79 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
323,701
Previous 1,113,582
70.93%
Holding current value
$3.79 Million
Previous $10.4 Million
70.93%
% of portfolio
0.02%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$137 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$128 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$126 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$103 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$101 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $705M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...